Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Amortizatization of Intangibles (2009)

Novartis Ag's (NVS) quarterly Amortizatization of Intangibles came in at -$37.0 million in Q2 2009, down 5.71% quarter-over-quarter from -$35.0 million in Q1 2009.

Analysis

Novartis Ag (NVS) Amortizatization of Intangibles (2009) Analysis & Trends

Novartis Ag has disclosed Amortizatization of Intangibles across 1 years of filings, most recently posting -$37.0 million for Q2 2009.

  • In Q2 2009, Amortizatization of Intangibles changed N/A year-over-year to -$37.0 million; the TTM figure through Jun 2009 stood at -$182.0 million (changed N/A YoY), while the FY2023 annual figure was -$32.0 million, up 89.33% from the prior year.
  • Amortizatization of Intangibles came in at -$37.0 million for Q2 2009 at Novartis Ag, down from -$35.0 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of -$35.0 million in Q1 2009 to a low of -$37.0 million in Q2 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 984.00 Mn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - 4.33 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2009 -37.00 Mn
Mar 31, 2009 -35.00 Mn